Determination of beta-lactamase types of clinical strains of bacteria using a modified microiodometric method

The substrate profiles and sensitivity to dicloxacillin inhibition were studied in the enzymes of the clinical strains of Pseudomonas aeruginosa and the transconjugants of E. coli carrying the plasmids discovered earlier in P. aeruginosa. The study was performed with a modified microiodometric method for determination of the activity of beta-lactamases. According to the M. Richmond classification of beta-lactamases the enzymes detected in P. aeruginosa strains 4529, 5290 and 9902 may correspond to the 5th class, the enzymes of P. aeruginosa strain 8208 to the 2nd class and the beta-lactamases of the E. coli transconjugants to the 3rd class. Two different beta-lactamases were detected in P. aeruginosa strain 10294.     

Dynamics of the strength of the rat left ventricle wall in experimental uncomplicated myocardial infarction

Left ventricular wall stability was studied in 131 normal rats at different terms of uncomplicated experimental myocardial infarction. Left ventricular wall stability was estimated by the normal effort required for its destruction. Normal left ventricular wall could stand the pressure of 1.1 X 10(5) Pa. During ischemic phase of myocardial infarction the wall stability in the infarction area increased up to 1.5 X 10(5) Pa. It diminished during necrotic phase, however timely started repair processes did not let it drop lower than 1.0 X 10(5) Pa. The mechanisms of preserving ventricular wall stability in the infarction area were studied in detail.     

Evolutionary changes in the structural and regulatory regions of aminoglycoside-3'-phosphotransferase type I gene of E. coli

To investigate the evolutionary relationships between the aph(3') genes from different plasmids, the nucleotide sequence of the aph(3') gene from the E. coli R plasmid was determined and compared with the known aph(3') genes of Tn903 and Tn4352. Three point mutations in the structural part of the cloned aph(3') gene caused amino acid changes in the enzyme molecule at positions 19, 27 and 48 beginning from the start codon. The structural part of the gene was followed by two stop codons and a long DNA region containing no nucleotide sequences homologous to the sequences of Tn903 or Tn4352. Both the cloned aph(3') gene and Tn4352 were limited on the left by the spacer sequence and the insertion sequence IS176. Twenty one base pairs deletion abolished the -35 sequence of the promoter suggested for the aph(3') gene of Tn4352 and resulted in formation of a fusion promoter utilizing the -35 box of IS176 and the -10 box of the aph(3') gene. The distance between the -35 and -10 sequences changed from 18 to 17 bp. Changes in the cloned aph(3') gene and the flanking DNA regions resulted in formation of a new promoter and loss of the right IS176 element.     

DNA probes for studies of aminoglycoside resistance in enterobacteriaceae clinical strains

World Journal of Microbiology and Biotechnology -     

Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of ��-Lactamases

A major mechanism of bacterial resistance to β-lactam antibiotics (penicillins, cephalosporins, carbapenems, etc.) is the production of β-lactamases. A handful of class A β-lactamases have been discovered that have acquired the ability to turn over carbapenem antibiotics. This is a disconcerting development, as carbapenems are often considered last resort antibiotics in the treatment of difficult infections. The GES family of β-lactamases constitutes a group of extended spectrum resistance enzymes that hydrolyze penicillins and cephalosporins avidly. A single amino acid substitution at position 170 has expanded the breadth of activity to include carbapenems. The basis for this expansion of activity is investigated in this first report of detailed steady-state and pre-steady-state kinetics of carbapenem hydrolysis, performed with a class A carbapenemase. Monitoring the turnover of imipenem (a carbapenem) by GES-1 (Gly-170) revealed the acylation step as rate-limiting. GES-2 (Asn-170) has an enhanced rate of acylation, compared with GES-1, and no longer has a single rate-determining step. Both the acylation and deacylation steps are of equal magnitude. GES-5 (Ser-170) exhibits an enhancement of the rate constant for acylation by a remarkable 5000-fold, whereby the enzyme acylation event is no longer rate-limiting. This carbapenemase exhibits k_cat/K_m of 3 × 10⁵ m⁻¹s⁻¹, which is sufficient for manifestation of resistance against imipenem.Bacterial production of β-lactamases is a primary mechanism of resistance to β-lactam antibiotics (1). These enzymes hydrolytically process the β-lactam bond of the antibiotic, and by so doing, inactivate them. Four classes of β-lactamases, A, B, C, and D, are known, of which the class A enzymes are most prevalent (1, 2). Enzymes belonging to classes A, C, and D are serine-dependent. A critical active site serine in these enzymes experiences acylation by the antibiotic followed by deacylation. The mechanistic details of the deacylation steps vary for each class (1). Class B enzymes are zinc-dependent, and their mechanistic details are distinct. Random mutations in the genes for these enzymes have allowed for selection of novel variants within the clinic having an increased breadth for substrate preference (3). Variants of β-lactamases with the ability to turn over both penicillins and cephalosporins are referred to as extended spectrum β-lactamases (4). Extended spectrum β-lactamases typically do not have the ability to hydrolyze carbapenems; however, exceptions to this rule are emerging among members of classes A, B, and D and are called carbapenemases (5, 6). Within class A, members of the KPC and GES families are becoming increasingly problematic within the clinic (3, 5, 7). The GES type class A β-lactamases were identified for the first time only 10 years ago, but they have been increasingly detected worldwide among Gram-negative bacteria (3). The first variants detected were plasmid borne and isolated from Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Enterobacter cloacae (8–14); however, newer variants have been identified in the chromosome of P. aeruginosa (15, 16). A distinguishing characteristic of this family of enzymes is its ability to develop resistance to all classes of β-lactam antibiotics, including third-generation cephalosporins, cephamycins, monobactams, and/or carbapenems. This is in stark contrast to “classical” β-lactamases, such as the TEM family of enzymes, which also rapidly evolved to produce numerous extended spectrum and inhibitor-resistant variants, yet have failed to evolve activity against carbapenem antibiotics. This combination of resistance to both extended spectrum β-lactams and carbapenem antibiotics makes the organisms that harbor the genes for these enzymes dangerous in a clinical setting as treatment options dwindle.GES-1, the first member of the GES family to be identified, has no significant ability to hydrolyze carbapenems, leading to its classification as only an extended spectrum β-lactamase (10). Other GES-type enzymes were later discovered with increased resistance to carbapenems. Two of these variants, GES-2 and -5, contain only a single amino acid substitution compared with the sequence of GES-1, both at position 170 (Ambler numbering is used) (17). This position is located within an Ω-loop forming one of the walls of the active site (1). The canonical residue at this position of class A β-lactamases is asparagine, which is found in GES-2. However, GES-1 contains a glycine, and GES-5 contains a serine (17). We recently solved the x-ray crystal structure of the GES-1 enzyme; however, it was not clear from the structural data why such a substitution would convey resistance in GES-2 and -5, in contrast to the case of GES-1, which does not (18). The mechanistic basis for the extended profile for resistance is not known, and it is the subject of study in this report. Previous kinetic analyses of class A carbapenemases, including GES enzymes, have been limited to steady-state kinetic parameters (8, 10, 11). In this report, we have performed an in-depth analysis of the GES family, including both steady-state and the first pre-steady-state analyses (for any class A carbapenemase) to elucidate the nature of the microscopic steps (binding, acylation, deacylation, and product release) in the turnover process by these clinically important enzymes.     

The effect of long-term lactobacilli (lactic acid bacteria) enteral treatment on the central nervous system of growing rats

The aim of this study was to explore the relationship between consumption of large doses of lactic acid bacteria (LAB) and the behaviour and brain morphobiochemistry of normal growing rats. Four groups of rats were treated with LAB cultures twice daily for 6 months. The control group received 1 ml of saline per treatment, while two experimental groups received 1 ml of living bacteria (Lactobacillus plantarum and Lactobacillus fermentum, respectively) and the remaining group received a heat-treated (inactivated) L. fermentum culture. After 2 and 6 months of treatment, respectively, eight animals from each group were sacrificed, and specimens were taken for further analyses. The behaviour of the rats was evaluated five times in an open-field test at monthly intervals throughout the study. Lactobacilli treatment for 2 months induced changes in the motoric behaviour of the rats. The concentration of the astrocytesoluble and filament glial fibrillary acidic protein (GFAP) decreased in the posterior part of the hemispheres, including the thalamus, hippocampus and cortex of the rats treated with L. fermentum. A greater decrease in filament GFAP (up to 50%) was shown in the group receiving the live form of L. fermentum. In contrast, the GFAP in the live L. plantarum-treated group increased, showing elevated levels of the soluble and filament forms of GFAP in the posterior part of the hemispheres.A 60–66% decrease in the amount of the astrocyte-specific Ca-binding protein S-100b was shown in the posterior parts of the hemispheres and in the hindbrain of rats given LAB for 2 months.Prolonged feeding with LAB for 4 months up to full adulthood led to a further decrease in astrocyte reaction, reflected as an additional decrease in the amount of soluble GFAP and locomotor activity in all experimental groups. The changes in filament GFAP and S-100b appeared to disappear after prolonged feeding (total of 6 months) with LAB.In summary, LAB dietary treatment affected the ontogenetic development of the astrocytes, with the highest intensity observed in the early stages of rat development. It can be postulated that LAB treatment may play a preventive role in neurological diseases by decreasing astrocyte reaction and, consequently, lowering locomotor activity.     

Aminoglycoside 2'-phosphotransferase type IIIa from Enterococcus

Aminoglycoside 2'-phosphotransferases mediate high level resistance to aminoglycoside antibiotics in Gram-positive microorganisms, thus posing a serious threat to the treatment of serious enterococcal infections. This work reports on cloning, purification, and detailed mechanistic characterization of aminoglycoside 2'-phosphotransferase, known as type Ic enzyme. In an unexpected finding, the enzyme exhibits strong preference for guanosine triphosphate over adenosine triphosphate as the phosphate donor, a unique observation among all characterized aminoglycoside phosphotransferases. The enzyme phosphorylates only certain 4,6-disubstituted aminoglycosides exclusively at the 2'-hydroxyl with k(cat) values of 0.5-1.0 s(-1) and K(m) values in the nanomolar range for all substrates but kanamycin A. Based on this unique substrate profile, the enzyme is renamed aminoglycoside 2'-phosphotransferase type IIIa. Product and dead-end inhibition patterns indicated a random sequential Bi Bi mechanism. Both the solvent viscosity effect and determination of the rate constant for dissociation of guanosine triphosphate indicated that at pH 7.5 the release of guanosine triphosphate is rate-limiting. A computational model for the enzyme is presented that sheds light on the structural aspects of interest in this family of enzymes.     

Endothelial progenitor cells are integrated in newly formed capillaries and alter adjacent fibrovascular tissue after subcutaneous implantation in a fibrin matrix

Vascularization of bioartificial matrices is crucial for successful tissue engineering. Endothelial progenitor cells (EPC) have shown vascularization potential in ischemic conditions and may also support blood vessel formation in tissue-engineered matrices. The aim of our study was to investigate the impact of a well-characterized murine embryonal EPC line (T17b-EPC) on vascularization and fibrovascular granulation tissue formation after suspension in a fibrine matrix followed by subcutaneous implantation in a separation chamber in rats. EPC were fluorescently labelled in vitro prior to implantation. After 3, 7 or 14 days, animals were killed followed by explantation and histological analysis of the constructs. Before the end of the experiment, Bandeirea Simplicifolia lectin was intravenously injected to mark the vascular ingrowth into the implanted constructs. The transplanted cells were histologically detected at all time-points and located almost exclusively within the fibrin matrix at day 3 but the number of cells in the clot continuously decreased over day 7 to day 14. Conversely, cells were detected within the newly formed granulation tissue in increasing numbers from day 3 over day 7 to day 14. Transplanted cells were also found in the intermuscular septa. Cell viability was confirmed by use of an EPC clone expressing β-galactosidase. Fluorescence microscopy demonstrated integration of the transplanted cells in newly formed blood vessels within the fibrovascular granulation tissue adjacent to the fibrin clot. Presence of cells in the fibrin clot lead to thicker granulation tissue and an increased blood vessel diameter compared to cell-free controls. Organ standard controls showed presence of the transplanted cells in spleens at day 14 after transplantation. In summary, EPC exhibited biological activity after subcutaneous implantation in a fibrin matrix by migration from the fibrin clot into the granulation tissue and along intermuscular septae, undergoing differentiation into mature endothelial cells and integration into newly formed blood vessels and altering fibrovascular granulation tissue development. EPC may hold promise to modulate blood vessel formation in bioartificial matrices.     

Cholesterol modulates interaction between an amphipathic class A peptide, Ac-18A-NH2, and phosphatidylcholine bilayers

Cholesterol (Chol) in phosphatidylcholine large unilamellar vesicles (PC LUV) modulated interaction of the bilayers with a class A amphipathic peptide, Ac-18A-NH2: Chol increased the peptide binding capacity and reduced the affinity together with the peptide-induced leakage of calcein from LUV. Similar effects of Chol have been observed on the interaction of LUV with apoA-I [Saito, H., Miyako, Y., Handa, T., and Miyajima, K. (1997) J. Lipid Res. 38, 287-294]. Circular dichroism (CD) spectra of the peptide indicated a similar helical structure formation in LUV with and without Chol. The fluorescence spectral shift, quantum yield, anisotropy, and acrylamide-quenching of the peptide Trp indicated that in PC:Chol (3:2) LUV, Ac-18A-NH2 was located in a more polar membrane environment with increased motional freedom and greater accessibility to the aqueous medium. Fluorescence energy transfer from the Trp indole ring to acceptors situated at different depths in the bilayers revealed that the amphipathic peptide penetrated the hydrophobic interior of PC bilayers, while the peptide was located at the polar zwitterionic surface in PC:Chol LUV. The inclusion of Chol causes the headgroup separation of PC at the surface of LUV and increases the binding maximum of the wedge-shaped amphipathic peptide without disrupting the membrane structure. In addition, the rigidifying effect of Chol on PC acyl chains prevents the penetration of the peptide into the bilayer interior. These findings imply that Chol in membranes affects the binding and motional freedom of exchangeable plasma apolipoproteins containing class A amphipathic sequences, e.g., apoA-I and apoCs.